Correlation Between Orofacial Pain and Sensory and Autonomic Neuropathies
Shruti Handa,Megan Heffernan,Summer Tan,David Keith,Annika Rosén,Hsinlin Cheng
DOI: https://doi.org/10.2147/jpr.s475528
IF: 2.8319
2024-10-10
Journal of Pain Research
Abstract:Shruti Handa, 1 Megan R Heffernan, 2 Summer Tan, 3 David A Keith, 1 Annika Rosén, 4– 6 Hsinlin Thomas Cheng 7 1 Division of Oral and Maxillofacial Surgery, Department of Surgery, Massachusetts General Hospital and Harvard School of Dental Medicine, Boston, MA, USA; 2 Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; 3 Department of Dentistry, Harvard School of Dental Medicine, Boston, MA, USA; 4 Department of Oral and Maxillofacial Surgery, Eastman Institute, Stockholm, Sweden; 5 Department of Clinical Dentistry, University of Bergen, Bergen, Norway; 6 Department of Oral and Maxillofacial Surgery, Haukeland University Hospital, Bergen, Norway; 7 Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA Correspondence: Shruti Handa, Department of Surgery, Massachusetts General Hospital, 165 Cambridge Street, Suite &num401, Boston, Massachusetts, 02114, USA, Email Purpose: Orofacial Pain (OFP) affects 15% of the general population. OFP conditions can be myofascial, also known as temporomandibular disorders (TMDs) or neuropathic. The underlying pathophysiology in several chronic OFP conditions, is unknown. Small fiber neuropathy (SFN) is a disorder of thinly myelinated A-delta and non-myelinated C-fibers and can manifest as sensory and autonomic neuropathies. SFN has been demonstrated in some OFP conditions. Our study aims to assess the presence of OFP in patients with sensory and autonomic neuropathies and assess the correlation between OFP, skin biopsy and autonomic dysfunction. Patients and Methods: This is a retrospective study (2018– 2020) of patients from the SFN registry, Massachusetts General Hospital, Boston, USA, for the presence of OFP. All patients were included. Primary outcome: Prevalence of OFP in patients with chronic neuropathies. Secondary outcomes: Correlation between OFP and skin biopsy, dysautonomia, headaches, chronic nociceptive pain, psychological conditions, and patient factors, such as mean age and BMI. Results: Charts of 450 patients with sensory and autonomic neuropathies were reviewed. 22.67% (n=102) had OFP. The mean (range) age at biopsy in patients with OFP was 48.36 (20– 81) years, female: male ratio 3.25:1. More OFP patients had negative skin biopsy results (p value 30 (p value 0.025). Dysautonomia was significantly higher in patients with TMDs when compared to the ones without TMDs (p value 0.030). There was no significant difference in mean age, gender predilection, presence of headaches, peripheral neuropathies, and nociceptive pain between patients with and without OFP. Conclusion: OFP and sensory neuropathies can be overlapping conditions. Patients presenting with concomitant TMD and dysautonomia can be further tested for SFN. This can further help us understand a correlation if any, between idiopathic TMD/OFP conditions and SFN and further our understanding of the pathophysiology of these conditions. Keywords: idiopathic facial pain, orofacial pain, temporomandibular disorders, skin biopsy, autonomic dysfunction, sensory neuropathic pain, dysautonomia, small fiber neuropathy Orofacial pain (OFP) is a term used to describe pain affecting the face and/or the oral structures. 1 The prevalence of OFP in the general population is up to 15% with a high prevalence rate among young and middle-aged women. 2 Chronic OFP conditions can be difficult to diagnose due to the varied signs and symptoms, the complex anatomy of the region and lack of objective testing in most cases. 3 OFP conditions can be categorized into myofascial, commonly known as temporomandibular disorders (TMDs) and neuropathies, which include persistent idiopathic facial pain (PIFP), persistent idiopathic dentoalveolar pain (PIDP), idiopathic burning mouth syndrome (BMS) and trigeminal neuralgia (TN) etc. 4 As the underlying etiology and pathogenesis of these conditions are mostly unknown, treatment is nonspecific and comprises management of the symptoms, rather than addressing the underlying disease process. Hence, improvement is not assured, and most cases will need lifetime pain management. 5 The financial burden of facial pain is approximately 2032 USD in 2017 per person per 6-month period. 6 Furthermore, patients with chronic OFP can have difficulty maintaining nutrition and social interactions. As such, OFP conditions have a huge emotional and financial impact on society and the individuals involved. Sm -Abstract Truncated-
clinical neurology